Quoin Pharmaceuticals Ltd.
QNRX | NASDAQ
$6.90
-$0.16 (-2.27%)
At close: Sep 21, 2026, 4:00 PM ET
$6.90
$0 (0.00%)
Pre-market:
Sep 22, 2026, 6:06 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.36 | -0.34 | -0.51 | -25.96 | -0.33 | -514.87 |
PEG Ratio | 0.02 | 0 | 0 | 0.26 | 0 | 6.44 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.65 | 0.33 | 0.78 | 32.52 | 23.22 | -137.47 |
P/FCF Ratio | -1.60 | -0.39 | -0.56 | -27.59 | -2.40 | -620.57 |
P/OCF Ratio | -1.60 | -0.39 | -0.56 | -28.40 | -2.67 | -678.52 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | -0.18 |
Quick Ratio | 3.61 | 3.57 | 3.15 | 3.79 | 1.79 | 0.06 |
Current Ratio | 3.61 | 3.57 | 3.15 | 3.79 | 1.79 | 0.06 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -12.96 | -5.56 | -1.41 |
Return on Equity | -120.47% | -97.37% | -153.36% | -126.66% | -3.27K% | 31.71% |
Return on Assets | -77.51% | -57.05% | -71.38% | -64.89% | -229.38% | -152.08% |
Return on Invested Capital | -109.75% | -82.65% | -109.21% | -84.70% | -126.82% | 30.96% |
Dividend Yield | n/a | n/a | n/a | 27.10% | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | -695.69% | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | -687.39% | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove QNRX